American College of Clinical Pharmacy
      Search      Cart
         

ACCP Report - December 2018

Pharmacotherapy Publications, Inc. – Closing Out 2018 New and Improved

Written by Leigh Ann Ross, Pharm.D., FCCP, BCPS
Chair, Pharmacotherapy Publications, Inc.



“New and improved” summarizes much of 2018 for Pharmacotherapy Publications, Inc. (PPI), the corporate journal-publishing unit affiliated with ACCP. The “new” second official journal of ACCP, the Journal of the American College of Clinical Pharmacy (JACCP), published its first issue in October 2018. Editor-in-Chief Jerry L. Bauman and Associate Editors Robert B. Parker, Beth Bryles Phillips, and Alan J. Zillich assembled a 26-member editorial board and produced two issues of JACCP in 2018, publishing papers across the spectrum of clinical pharmacy practice. Watch for six issues filled with high-quality research, insightful reviews, and compelling editorials in 2019.

The “improved” impact factor of ACCP’s first official journal, Pharmacotherapy, was announced in the summer of 2018. The impact factor is a vital measure in biomedical publishing of a journal’s impact on its field, and Pharmacotherapy’s current impact factor of 3.196 is the highest in the journal’s history. Editor-in-Chief C. Lindsay DeVane, the 10-member scientific editorial council, and the 47-member editorial board continue to invite and select the highest-quality papers in the field of pharmacology and drug therapy. These PPI editors, board members, and staff look forward to continuing to serve Pharmacotherapy’s readers and authors in 2019 with an online-only publication. ACCP members will continue to receive full-text access to both Pharmacotherapy and JACCP electronically.

Moreover, although all PPI directors, editors, and staff are pleased to reflect on everything that was “new and improved” in 2018, their focus is on the future. Advancement and dissemination of scholarship in pharmacotherapy and clinical pharmacy worldwide will remain a top priority for all such personnel. They will continue to deliver value to authors, readers, and reviewers by sponsoring live programming focused on scholar development; publishing regular podcasts; disseminating research and resources through social media outlets; and exploring new publications and services.